| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.069 | 0.4 |